Switch to: References

Add citations

You must login to add citations.
  1. Public Preferences about Fairness and the Ethics of Allocating Scarce Medical Interventions.Govind Persad - 2017 - In Meng Li & David P. Tracer (eds.), Interdisciplinary Perspectives on Fairness, Equity, and Justice. Springer. pp. 51-65.
    This chapter examines how social- scientific research on public preferences bears on the ethical question of how those resources should in fact be allocated, and explain how social-scientific researchers might find an understanding of work in ethics useful as they design mechanisms for data collection and analysis. I proceed by first distinguishing the methodologies of social science and ethics. I then provide an overview of different approaches to the ethics of allocating scarce medical interventions, including an approach—the complete lives system—which (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Let Us Be Fair to 5-Year-Olds: Priority for the Young in the Allocation of Scarce Health Resources.Kelsey Gipe & Samuel J. Kerstein - 2018 - Public Health Ethics 11 (3):325-335.
    Life-saving health resources like organs for transplant and experimental medications are persistently scarce. How ought we, morally speaking, to ration these resources? Many hold that, in any morally acceptable allocation scheme, the young should to some extent be prioritized over the old. Govind Persad, Alan Wertheimer and Ezekiel Emanuel propose a multi-principle allocation scheme called the Complete Lives System, according to which persons roughly between 15 and 40 years old get priority over younger children and older adults, other things being (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Practical allocation system for the distribution of specialised care during cellular therapy access scarcity.Andrew Hantel, Gregory A. Abel & Mark Siegler - 2019 - Journal of Medical Ethics 45 (8):532-537.
    Novel cellular therapy techniques promise to cure many haematology patients refractory to other treatment modalities. These therapies are intensive and require referral to and care from specialised providers. In the USA, this pool of providers is not expanding at a rate necessary to meet expected demand; therefore, access scarcity appears forthcoming and is likely to be widespread. To maintain fair access to these scarce and curative therapies, we must prospectively create a just and practical system to distribute care. In this (...)
    Download  
     
    Export citation  
     
    Bookmark